https://scholars.lib.ntu.edu.tw/handle/123456789/616493
標題: | Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial | 作者: | Lu S. Wang Q. Zhang G. Dong X. Yang C.-T. Song Y. Chang G.-C. Lu Y. Pan H. Chiu C.-H. Wang Z. Feng J. Zhou J. Xu X. Guo R. Chen J. Yang H. Chen Y. Yu Z. Shiah H.-S. Wang C.-C. Yang N. Fang J. Wang P. Wang K. Hu Y. He J. Wang Z. Shi J. Chen S. Wu Q. Sun C. Li C. Wei H. Cheng Y. Su W.-C. Hsia T.-C. Cui J. Sun Y. Ou S.-H.I. Zhu V.W. CHIH-HSIN YANG |
公開日期: | 2022 | 出版社: | Elsevier Inc. | 卷: | 17 | 期: | 3 | 起(迄)頁: | 411-422 | 來源出版物: | Journal of Thoracic Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120306113&doi=10.1016%2fj.jtho.2021.10.024&partnerID=40&md5=8a4258346f70774891f72103058c7a74 https://scholars.lib.ntu.edu.tw/handle/123456789/616493 |
ISSN: | 1556-0864 | DOI: | 10.1016/j.jtho.2021.10.024 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。